Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

<p>CINCINNATI, Ohio, June 28, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company spanning multiple sectors, today announced preliminary preclinical data supporting the use of its norovirus shell and protrusion (“S&P”) virus-like particle (“VLP”) platform to develop a novel monkeypox vaccine candidate. In August […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/blue-water-biotech-announces-preclinical-data-supporting-immunogenicity-of-novel-monkeypox-vaccine-utilizing-norovirus-virus-like-particle-platform/">Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>